Literature DB >> 33317562

Survival differences by ethnicity among patients diagnosed with bladder cancer.

Boda Guo1,2, Ming Liu3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33317562      PMCID: PMC7737256          DOI: 10.1186/s12967-020-02668-3

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


× No keyword cloud information.
Dear Editor, We read the study by Fang et al. [1] with great interest and would like to congratulate the authors for their superb study. The authors compared the oncologic outcomes of bladder cancer (BC) of different ethnicities, which may aid in clinical decision-making. As such, there are a few points that we would like to bring up. Their study included patients with primary BC but did not exclude multiple primary cancers. However, another SEER-based study showed BC patients were at a significantly higher risk of developing a second malignancy, which may affect patients’ survival [2]. BC surgery in the SEER database includes transurethral resection of bladder, partial cystectomy and complete cystectomy, etc. It would be more meaningful to stratify patients according to the type of surgery that they received; in this way, readers can easily see which surgical treatment improves BC patient’s survival better. Some of the patients included in the analysis received radiotherapy or chemotherapy. These two types of treatment should be taken into consideration since prior studies showed that both radiotherapy and chemotherapy hold great potential in the management of BC patients [3, 4].
  4 in total

1.  Neoadjuvant Radiotherapy Improves Survival in Patients With T2b/T3 Bladder Cancer: A Population-Based Analysis.

Authors:  Dayssy Alexandra Diaz; Alan Pollack; Isildinha M Reis; Omar Mahmoud; Mark L Gonzalgo; Adrian Ishkanian; Gustavo Fernandez; Murugesan Manoharan; Matthew C Abramowitz
Journal:  Clin Genitourin Cancer       Date:  2015-03-05       Impact factor: 2.872

2.  Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.

Authors:  Matthew D Galsky; Kristian D Stensland; Erin Moshier; John P Sfakianos; Russell B McBride; Che-Kai Tsao; Martin Casey; Paolo Boffetta; William K Oh; Madhu Mazumdar; Juan P Wisnivesky
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

3.  Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.

Authors:  Amit Khanal; Nibash Budhathoki; Vijay Pal Singh; Binay K Shah
Journal:  Anticancer Res       Date:  2017-04       Impact factor: 2.480

4.  Ethnicity and survival in bladder cancer: a population-based study based on the SEER database.

Authors:  Wei Fang; Zhi-Yan Yang; Ting-Yu Chen; Xian-Feng Shen; Chao Zhang
Journal:  J Transl Med       Date:  2020-03-30       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.